Joseph Armenia, MD
Ophthalmic Plastic and Reconstructive Surgery · Webster, NYNPI 1770840720
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,805 of the $38,415 with a category attached, or 85.4%. Amgen accounts for 99.6% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $10,862, more than ten times the $158 reported in 2020.
Across 94 payments — averaging $408.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$38K
- Alcon$156
What the payments were for
- Consulting fees$8502%
- Speaking & faculty fees$32,80585%
- Travel & lodging$6292%
- Food & beverage$4,10811%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,415 in reported general payments places this provider in the 80th percentile of 25 ophthalmic plastic and reconstructive surgery providers in New York.
See all ophthalmic plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 482 | $5,907 |
| Prednisolone Acetate | 12 | $586 |
| Doxycycline Hyclate | 18 | $449 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 261 | $324 |
| Methylprednisolone | 22 | $289 |
| ErythromycinErythromycin Base | 18 | $194 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 15 | $105 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Webster
- Sean MoganWebster$3K
- Gary Lelli JrNew York$263K
- James ChelnisNew York$223K
- Edward WladisSlingerlands$179K
- George SalloumNorth Syracuse$141K
- Bryant CarruthNorth Syracuse$38K
- Kira SegalNew York$12K
- Leon RafailovSmithtown$5K
- Daniel KhodadadianGreat Neck$4K
- Katherine WhippleRochester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.